Position in MGTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,173,316
+$690,426 QoQ
Shares Held
86,848
+55.8% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. MGTX ranks #123 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in MGTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,173,316 | 86,848 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $482,890 | 55,761 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $446,845 | 56,207 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $499,388 | 60,679 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $415,421 | 63,715 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $394,779 | 58,227 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $334,286 | 54,891 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $203,904 | 48,898 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $223,113 | 52,996 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $290,255 | 47,818 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $326,191 | 46,466 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $228,904 | 46,620 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $317,056 | 47,181 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $273,632 | 52,927 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $306,681 | 47,037 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $392,158 | 46,630 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $332,837 | 43,968 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $525,718 | 37,958 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $841,511 | 35,447 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $461,484 | 35,014 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $521,017 | 33,614 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $325,439 | 22,553 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $343,647 | 22,698 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $274,994 | 20,770 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $300,354 | 23,990 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $270,748 | 20,145 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||